Tuberculosis (TB) is a highly infectious disease and a major global health problem, especially in countries with developing health care systems. Because there is no fast, easy way to detect TB, the deadly infection can spread quickly through communities. Now, a team reports in ACS Sensors the development of a rapid, sensitive and low-cost method for detecting the disease in resource-limited areas.
The typical way that physicians screen for TB, which is caused by the bacterium Mycobacterium tuberculosis (Mtb), is with a tuberculin skin test or an examination of a patient’s sputum under a microscope. To weed out false positives, a more reliable test that involves growing Mtb cultures can be performed, but that requires weeks to complete. For all of these methods, experienced personnel are needed. Another approach that is both quick and accurate is a nucleic acid amplification test, which makes many copies of the Mtb DNA in a sample. However, it is expensive and requires a lab setting. So, Matt Trau, Nicholas P. West and colleagues set out to create a simple, inexpensive and reliable way to quickly test for TB.
The researchers began with a newly created nucleic acid amplification test that does not require expensive lab equipment to detect Mtb. Still, this modified test typically uses costly fluorescence technology to read the results. So the team substituted the fluorescence detector with a colorimetric assay that changes to a blue hue if the infection is present, allowing health care workers to identify positive test results right away with the naked eye. They demonstrated how the modified diagnostic could be put on cheap, disposable electrochemical sensors for increased sensitivity, even in the field. Because the assay is inexpensive, quick and highly specific for the Mtb bacterium, the researchers say it could have a big impact in low-resource communities.
The Latest on: Tuberculosis
via Google News
The Latest on: Tuberculosis
- One small drug, one giant leap for tuberculosis treatmenton August 17, 2019 at 5:00 am
The views expressed by contributors are their own and not the view of The Hill The infectious disease the single-handedly kills the most humans on an annual basis today, in 2019, is tuberculosis (TB).
- Scientists Discover New Cure for the Deadliest Strain of Tuberculosison August 16, 2019 at 7:38 am
TSAKANE, South Africa — When she joined a trial of new tuberculosis drugs, the dying young woman weighed just 57 pounds. Stricken with a deadly strain of the disease, she was mortally terrified. Local ...
- A New Dose of Hope in the Battle With Tuberculosison August 16, 2019 at 7:36 am
Tuberculosis is the world’s deadliest infectious disease: Between 2007 and 2017, an estimated 94.5 million people caught tuberculosis, and more than 14 million died from it. Rising numbers are being ...
- Treatment for Extreme Drug-Resistant Tuberculosis Wins U.S. Government Approvalon August 16, 2019 at 6:49 am
The U.S. Food and Drug Administration has approved a drug regimen to treat an extreme form of multi-drug-resistant tuberculosis (TB). Nearly 90% of people infected with extensively drug-resistant (XDR ...
- How a new antibiotic destroys extremely drug-resistant tuberculosison August 16, 2019 at 6:25 am
The Food and Drug Administration on Wednesday approved a new antibiotic that, when combined with two existing antibiotics, can tackle the most formidable and deadly forms of tuberculosis.
- A new FDA-approved drug takes aim at a deadly form of tuberculosison August 16, 2019 at 3:24 am
An especially dangerous type of tuberculosis may have met its match. The U.S. Food and Drug Administration announced August 14 that it has approved the antibiotic pretomanid to help tackle what’s ...
- New treatment approved for drug-resistant tuberculosison August 15, 2019 at 11:18 am
(CNN)The US Food and Drug Administration approved a new treatment for highly drug-resistant tuberculosis, offering new hope in the fight against the world's most deadly infectious disease. TB most ...
- FDA approves drug for most deadly form of tuberculosison August 15, 2019 at 10:03 am
(HealthDay)—A new drug has been approved as part of a powerful, three-pronged treatment regimen for the most deadly strain of tuberculosis, the U.S. Food and Drug Administration announced Wednesday.
- The burdens of tuberculosis on patients with malignancy: incidence, mortality and relapseon August 15, 2019 at 2:38 am
Population with malignancy is growing worldwide; however, its tuberculosis (TB) burden including remains unclear regarding incidence, mortality, and relapse. We retrieved information and identified ...
- FDA approves tuberculosis drug that works on hard-to-treat caseson August 14, 2019 at 2:00 pm
U.S. regulators have approved a new tuberculosis medication that shortens and improves treatment for the hardest-to-treat cases — a worsening problem in many poor countries. Decades of incomplete or ...
via Bing News